Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.

PubWeight™: 2.55‹?› | Rank: Top 2%

🔗 View Article (PMID 11033431)

Published in Eur J Pharm Sci on October 01, 2000

Authors

C W Pouton1

Author Affiliations

1: Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK. c.w.pouton@bath.ac.uk

Articles citing this

The biophysics and cell biology of lipid droplets. Nat Rev Mol Cell Biol (2013) 1.98

Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J (2007) 1.59

Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm (2012) 1.25

Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS One (2013) 1.05

A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharm Res (2011) 1.02

Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech (2008) 1.02

Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. AAPS PharmSciTech (2002) 1.02

Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag (2007) 0.94

Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. J Adv Pharm Technol Res (2011) 0.92

Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm (2013) 0.92

Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech (2009) 0.91

Bioavailability of tocotrienols: evidence in human studies. Nutr Metab (Lond) (2014) 0.91

Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS PharmSciTech (2010) 0.89

Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form. AAPS PharmSciTech (2004) 0.86

Rice germ oil as multifunctional excipient in preparation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech (2012) 0.86

Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech (2008) 0.86

Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation. Int J Nanomedicine (2012) 0.85

Microemulgel: an overwhelming approach to improve therapeutic action of drug moiety. Saudi Pharm J (2014) 0.84

Self-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrate: preparation and evaluation. Int J Nanomedicine (2013) 0.84

Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation. J Control Release (2013) 0.82

Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs. Adv Pharm Bull (2015) 0.82

Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation. Int J Nanomedicine (2014) 0.82

One Polymorph and Various Morphologies of Phenytoin at a Silica Surface Due to Preparation Kinetics. Cryst Growth Des (2014) 0.81

Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies. AAPS J (2013) 0.81

Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement. J Pharm (Cairo) (2012) 0.81

In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate. AAPS J (2014) 0.80

Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Int J Nanomedicine (2014) 0.80

Computational prediction of drug solubility in lipid based formulation excipients. Pharm Res (2013) 0.80

Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80

Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion. AAPS PharmSciTech (2012) 0.79

Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design. Int J Nanomedicine (2015) 0.79

Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in-vitro assessment. AAPS PharmSciTech (2012) 0.79

Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10. Biomed Res Int (2014) 0.78

Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution. Saudi Pharm J (2015) 0.78

The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulations. AAPS PharmSciTech (2012) 0.78

A comparison between use of spray and freeze drying techniques for preparation of solid self-microemulsifying formulation of valsartan and in vitro and in vivo evaluation. Biomed Res Int (2013) 0.78

Design and development of a self-nanoemulsifying drug delivery system for telmisartan for oral drug delivery. Int J Pharm Investig (2011) 0.78

Molecular dynamics study of non-nucleoside reverse transcriptase inhibitor 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (TMC278/rilpivirine) aggregates: correlation between amphiphilic properties of the drug and oral bioavailability. J Med Chem (2009) 0.78

Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug. J R Soc Interface (2012) 0.77

Surface-Induced Polymorphism as a Tool for Enhanced Dissolution: The Example of Phenytoin. Cryst Growth Des (2015) 0.77

Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323. PLoS One (2015) 0.77

Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption. Int J Nanomedicine (2016) 0.77

SEDDS of gliclazide: Preparation and characterization by in-vitro, ex-vivo and in-vivo techniques. Saudi Pharm J (2013) 0.77

Application of Chemoenzymatic Hydrolysis in the Synthesis of 2-Monoacylglycerols. Tetrahedron (2012) 0.77

The preparation and evaluation of self-nanoemulsifying systems containing Swietenia oil and an examination of its anti-inflammatory effects. Int J Nanomedicine (2014) 0.77

Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study. Nutr J (2006) 0.77

Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Int J Nanomedicine (2015) 0.76

Tools for Early Prediction of Drug Loading in Lipid-Based Formulations. Mol Pharm (2015) 0.76

Self nanoemulsifying drug delivery system of stabilized ellagic acid-phospholipid complex with improved dissolution and permeability. Saudi Pharm J (2014) 0.76

Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier. AAPS PharmSciTech (2014) 0.76

Lipid-Based Drug Delivery Systems. J Pharm (Cairo) (2014) 0.76

Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses. Int J Mol Sci (2016) 0.76

Self-Microemulsifying Drug Delivery Systems: An Attractive Strategy for Enhanced Therapeutic Profile. Int Sch Res Notices (2014) 0.75

Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. Int J Nanomedicine (2016) 0.75

Development and characterization of dilutable self-microemulsifying premicroemulsion systems (SMEPMS) as templates for preparation of nanosized particulates. Int J Nanomedicine (2013) 0.75

Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems. AAPS J (2015) 0.75

Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design. AAPS PharmSciTech (2009) 0.75

Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations. Acta Pharm Sin B (2014) 0.75

Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation. Pharmaceutics (2016) 0.75

The In Vitro Lipolysis of Lipid-Based Drug Delivery Systems: A Newly Identified Relationship between Drug Release and Liquid Crystalline Phase. Biomed Res Int (2016) 0.75

Role of medium-chain fatty acids in the emulsification mechanistics of self-micro-emulsifying lipid formulations. Saudi Pharm J (2014) 0.75

Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb) (2016) 0.75

Development and evaluation of nanoemulsifying preconcentrate of curcumin for colon delivery. ScientificWorldJournal (2015) 0.75

Formulation and characterization of hydrochlorothiazide solid lipid microparticles based on lipid matrices of Irvingia fat. Int J Pharm Investig (2014) 0.75

Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib. AAPS PharmSciTech (2015) 0.75

Evaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs. J Pharm Sci (2013) 0.75

Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems. J Oncol (2017) 0.75